Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market
<p>Abstract</p> <p>Background</p> <p>The price of antiretroviral drugs (ARVs) in low income countries declined steadily in recent years. This raises concerns about the commercial viability of the market of ARVs in low income countries.</p> <p>Methods</p&g...
Main Authors: | Nakakeeto Olive N, Elliott Brian V |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | Globalization and Health |
Subjects: | |
Online Access: | http://www.globalizationandhealth.com/content/9/1/6 |
Similar Items
-
Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria
by: Muhammed O. Afolabi, et al.
Published: (2009-04-01) -
An appeal for large scale production of antiretroviral drugs in Africa
by: Nkamedjie Pete Patrick Martial, et al.
Published: (2016-09-01) -
Guidelines for antiretroviral therapy in adults
by: G Meintjes, et al.
Published: (2012-08-01) -
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy
by: Lucia Taramasso, et al.
Published: (2018-09-01) -
Effect of Antiretroviral Drug (arved) on the Kidney in Albino Rat
by: D E Peters, et al.
Published: (2014-07-01)